BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Clinical Outcome
3 results:

  • 1. Efficient detection of the V600E mutation of the BRAF gene in papillary thyroid carcinoma using multiplex allele-specific polymerase chain reaction combined with denaturing high-performance liquid chromatography.
    Gong RX; Gong YP; Yang J; Wei T; Li-Ling J; Zhu JQ
    Genet Mol Res; 2013 Oct; 12(4):4990-7. PubMed ID: 24301760
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Poorly differentiated follicular thyroid carcinoma: prognostic factors and relevance of histological classification.
    Pulcrano M; Boukheris H; Talbot M; Caillou B; Dupuy C; Virion A; De Vathaire F; Schlumberger M
    Thyroid; 2007 Jul; 17(7):639-46. PubMed ID: 17696834
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Does radioiodine therapy have disadvantageous effects in non-iodine accumulating differentiated thyroid carcinoma?
    Schaap J; Eustatia-Rutten CF; Stokkel M; Links TP; Diamant M; van der Velde EA; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):117-24. PubMed ID: 12100079
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.